Frontiers in Molecular Neuroscience,
Journal Year:
2024,
Volume and Issue:
17
Published: Aug. 30, 2024
Neuropathic
pain
(NP)
conditions
arising
from
injuries
to
the
nervous
system
due
trauma,
disease,
or
neurotoxins
are
chronic,
severe,
debilitating,
and
exceedingly
difficult
treat.
However,
mechanisms
of
NP
not
yet
clear.
Here
we
explored
role
Dock4,
an
atypical
Rac1
GEF,
in
development
NP.
The Journal of Headache and Pain,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: Jan. 27, 2025
Neuropathic
pain
poses
a
significant
clinical
challenge,
largely
due
to
the
incomplete
understanding
of
its
molecular
mechanisms,
particularly
role
mitochondrial
dysfunction.
Bioinformatics
analysis
revealed
that
pyroptosis
and
inflammatory
responses
induced
by
spared
nerve
injury
(SNI)
in
spinal
dorsal
horn
play
critical
initiation
persistence
neuropathic
pain.
Among
factors
involved,
TSPO
(translocator
protein)
emerged
as
key
regulator.
Our
experimental
findings
showed
expression
was
upregulated
during
pain,
accompanied
dysfunction,
specifically
manifested
impaired
biogenesis,
disrupted
dynamics
(including
insufficient
biogenesis
fusion-related
proteins,
well
significantly
increased
fission-related
proteins),
activation
pyroptosis.
Pharmacological
upregulation
TSPO,
but
not
downregulation,
effectively
alleviated
SNI-induced
hypersensitivity,
improving
function
reducing
Immunofluorescence
staining
confirmed
primarily
localized
astrocytes,
mirrored
protective
effects
on
health
prevention.
PCR
array
suggested
strong
association
between
regulation
pathway
AMPK-PGC-1α.
Notably,
inhibition
AMPK-PGC-1α
abolished
balance
suppression.
Furthermore,
Mendelian
randomization
GWAS
data
indicated
linked
relief.
Through
drug
screening,
docking,
behavioral
assays,
we
identified
zopiclone
promising
TSPO-targeting
for
treatment.
In
summary,
this
study
enhances
our
interplay
health,
highlighting
potential
therapeutic
target
management.
Brain Behavior and Immunity,
Journal Year:
2024,
Volume and Issue:
117, P. 51 - 65
Published: Jan. 6, 2024
Microglia,
resident
immune
cells
in
the
central
nervous
system,
play
a
role
neuroinflammation
and
development
of
neuropathic
pain.
We
found
that
stimulator
interferon
genes
(STING)
is
predominantly
expressed
spinal
microglia
upregulated
after
peripheral
nerve
injury.
However,
mechanical
allodynia,
as
marker
pain
following
injury,
did
not
require
microglial
STING
expression.
In
contrast,
activation
by
specific
agonists
(ADU-S100,
35
nmol)
significantly
alleviated
male
mice,
but
female
mice.
mice
leads
to
increase
proinflammatory
cytokines
may
counteract
analgesic
effect
ADU-S100.
Microglial
expression
type
I
interferon-ß
(IFN-ß)
signaling
were
required
for
effects
Mechanistically,
downstream
TANK-binding
kinase
1
(TBK1)
production
IFN-ß,
partly
account
observed.
These
findings
suggest
could
be
potential
therapeutic
intervention
pain,
particularly
males.
Neurochemical Research,
Journal Year:
2024,
Volume and Issue:
49(8), P. 1980 - 1992
Published: May 20, 2024
Abstract
The
complex
mechanism
of
neuropathic
pain
involves
various
aspects
both
central
and
peripheral
conduction
pathways.
An
effective
cure
for
therefore
remains
elusive.
We
found
that
deficiency
the
gene
Gdpd3
,
encoding
a
lysophospholipase
D
enzyme,
alleviates
inflammatory
responses
in
dorsal
root
ganglia
(DRG)
mice
under
reduces
PE
(20:4)
PGE2
DRG.
had
stronger
analgesic
effect
on
than
Celecoxib,
nonsteroidal
anti-inflammatory
drug.
also
interferes
with
polarization
macrophages,
switching
from
M1
towards
M2
phenotype.
PPARγ/
FABP4
pathway
was
screened
by
RNA
sequencing
as
functional
related
deficient
BMDMs
stimulated
LPS.
Both
protein
mRNA
levels
PPARγ
GDPD3
were
higher
those
litter
control
mice.
However,
GW9962
(inhibitor
PPARγ)
could
reverse
reprogramming
macrophages
caused
deficiency.
Therefore,
our
study
suggests
exerts
relieving
neuroinflammation
DRG
phenotype
to
M2,
which
mediated
through
pathway.
Brain,
Journal Year:
2024,
Volume and Issue:
147(7), P. 2507 - 2521
Published: April 4, 2024
Opioid
pain
medications,
such
as
morphine,
remain
the
mainstay
for
treating
severe
and
chronic
pain.
Prolonged
morphine
use,
however,
triggers
analgesic
tolerance
hyperalgesia
(OIH),
which
can
last
a
long
period
after
withdrawal.
How
induces
these
detrimental
side
effects
remains
unclear.
Here,
we
show
that
OIH
are
mediated
by
Tiam1-coordinated
synaptic
structural
functional
plasticity
in
spinal
nociceptive
network.
Tiam1
is
Rac1
GTPase
guanine
nucleotide
exchange
factor
promotes
excitatory
synaptogenesis
modulating
actin
cytoskeletal
dynamics.
We
found
prolonged
treatment
activated
dorsal
horn
ablation
from
neurons
eliminated
antinociceptive
OIH.
At
same
time,
pharmacological
blockade
of
Tiam1-Rac1
signalling
prevented
development
reserved
established
increased
dendritic
spine
density
NMDA
receptor
activity
neurons,
both
required
Tiam1.
Furthermore,
co-administration
inhibitor
NSC23766
was
sufficient
to
abrogate
management.
These
findings
identify
Tiam1-mediated
maladaptive
network
an
underlying
cause
maintenance
provide
promising
therapeutic
target
reduce
prolong
use
One
of
the
most
extensively
studied
members
Ras
superfamily
small
GTPases,
Rac1
is
an
intracellular
signal
transducer
that
remodels
actin
and
phosphorylation
signaling
networks.
Previous
studies
have
shown
Rac1-mediated
associated
with
hippocampal-dependent
working
memory
longer-term
forms
learning
can
modulate
both
pre-
postsynaptic
plasticity.
How
these
different
cognitive
functions
plasticity
mediated
by
are
linked,
however,
unclear.
Here,
we
show
spatial
selectively
impaired
following
expression
a
genetically
encoded
Rac1-inhibitor
at
presynaptic
terminals,
while
processes
affected
inhibition
sites.
To
investigate
regulatory
mechanisms
this
process,
leveraged
new
advances
in
mass
spectrometry
to
identify
proteomic
post-translational
landscape
signaling.
We
identified
serine/threonine
kinases
phosphorylated
cytoskeletal
synaptic
vesicle
proteins
enriched
active
Rac1.
The
sites
positions
likely
effects
on
vesicles.
Consistent
this,
also
report
changes
distribution
morphology
vesicles
ultrastructure
inhibition.
Overall,
study
reveals
previously
unrecognized
role
provides
insights
into
its
potential
mechanisms.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 19, 2024
Abstract
One
of
the
most
extensively
studied
members
Ras
superfamily
small
GTPases,
Rac1
is
an
intracellular
signal
transducer
that
remodels
actin
and
phosphorylation
signaling
networks.
Previous
studies
have
shown
Rac1-mediated
associated
with
hippocampal-dependent
working
memory
longer-term
forms
learning
can
modulate
both
pre-
postsynaptic
plasticity.
How
these
different
cognitive
functions
plasticity
mediated
by
are
linked,
however,
unclear.
Here,
we
show
spatial
selectively
impaired
following
expression
a
genetically
encoded
Rac1-inhibitor
at
presynaptic
terminals,
while
processes
affected
inhibition
sites.
To
investigate
regulatory
mechanisms
this
process,
leveraged
new
advances
in
mass
spectrometry
to
identify
proteomic
post-translational
landscape
signaling.
We
identified
serine/threonine
kinases
phosphorylated
cytoskeletal
synaptic
vesicle
proteins
enriched
active
Rac1.
The
sites
positions
likely
effects
on
vesicles.
Consistent
this,
also
report
changes
distribution
morphology
vesicles
ultrastructure
inhibition.
Overall,
study
reveals
previously
unrecognized
role
provides
insights
into
its
potential
mechanisms.